Parametrica Management LTD Reata Pharmaceuticals Inc Transaction History

Parametrica Management LTD

  • $83.5 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$78.27 - $151.29 $183,777 - $355,228
-2,348 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$94.25 - $132.81 $221,299 - $311,837
2,348 New
2,348 $228,000
Q4 2020

Feb 16, 2021
SELL
$102.03 - $184.62 $293,336 - $530,782
-2,875 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$93.53 - $163.34 $98,300 - $171,670
1,051 Added 57.62%
2,875 $280,000
Q2 2020

Aug 17, 2020
BUY
$126.3 - $176.56 $230,371 - $322,045
1,824 New
1,824 $283,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email